Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2026-05-21 @ 12:06 PM
Study NCT ID:
NCT01091168
Status:
COMPLETED
Last Update Posted:
2019-09-16
First Post:
2010-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Sponsor:
Pierre Fabre Medicament
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
L00070 IN 308 B0
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None